Mason Street Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,234
Closed -$2.02M 1406
2020
Q4
$2.02M Sell
6,234
-93
-1% -$30.2K 0.03% 625
2020
Q3
$1.75M Sell
6,327
-91
-1% -$25.2K 0.03% 589
2020
Q2
$1.55M Sell
6,418
-25
-0.4% -$6.04K 0.03% 631
2020
Q1
$935K Hold
6,443
0.02% 755
2019
Q4
$1.1M Sell
6,443
-22
-0.3% -$3.75K 0.02% 846
2019
Q3
$1.15M Buy
6,465
+29
+0.5% +$5.16K 0.02% 795
2019
Q2
$1.68M Buy
6,436
+4
+0.1% +$1.04K 0.04% 646
2019
Q1
$1.84M Buy
6,432
+82
+1% +$23.4K 0.04% 637
2018
Q4
$2.06M Buy
6,350
+41
+0.6% +$13.3K 0.05% 450
2018
Q3
$2.84M Buy
6,309
+381
+6% +$171K 0.06% 372
2018
Q2
$2.43M Sell
5,928
-15,199
-72% -$6.22M 0.05% 441
2018
Q1
$6.15M Buy
21,127
+432
+2% +$126K 0.14% 131
2017
Q4
$3.88M Sell
20,695
-100
-0.5% -$18.7K 0.09% 230
2017
Q3
$3.51M Buy
20,795
+888
+4% +$150K 0.08% 246
2017
Q2
$2.85M Buy
19,907
+778
+4% +$112K 0.07% 321
2017
Q1
$2.4M Buy
19,129
+300
+2% +$37.6K 0.06% 394
2016
Q4
$2.12M Buy
18,829
+312
+2% +$35.2K 0.06% 426
2016
Q3
$2.38M Buy
18,517
+587
+3% +$75.5K 0.07% 353
2016
Q2
$1.96M Buy
17,930
+620
+4% +$67.8K 0.06% 422
2016
Q1
$1.64M Buy
17,310
+11,020
+175% +$1.04M 0.05% 481
2015
Q4
$568K Buy
6,290
+590
+10% +$53.3K 0.02% 870
2015
Q3
$529K Buy
5,700
+511
+10% +$47.4K 0.02% 877
2015
Q2
$341K Buy
5,189
+277
+6% +$18.2K 0.01% 953
2015
Q1
$352K Buy
4,912
+177
+4% +$12.7K 0.01% 946
2014
Q4
$180K Buy
4,735
+191
+4% +$7.26K ﹤0.01% 1527
2014
Q3
$113K Buy
4,544
+77
+2% +$1.92K ﹤0.01% 1642
2014
Q2
$112K Buy
4,467
+140
+3% +$3.51K ﹤0.01% 1641
2014
Q1
$113K Sell
4,327
-1,258
-23% -$32.9K ﹤0.01% 1611
2013
Q4
$149K Buy
5,585
+445
+9% +$11.9K ﹤0.01% 1602
2013
Q3
$98K Buy
5,140
+256
+5% +$4.88K ﹤0.01% 1533
2013
Q2
$105K Buy
+4,884
New +$105K ﹤0.01% 1422